Literature DB >> 622386

Definition of the cell cycle segment with special sensitivity to vinblastine.

A M Chirife, G P Studzinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 622386     DOI： 10.3181/00379727-157-40022

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  Phase I evaluation of divided-dose vinblastine sulfate.

Authors:  P Schulman; D R Budman; V Vinciguerra; T J Degnan
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.

Authors:  R Ludwig; D S Alberts; T P Miller; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine.

Authors:  J A Young; S B Howell; M R Green
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.

Authors:  K Aoshiba; A Nagai; H Ueno; K Konno
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Vindesine receptors in cells of a human leukaemia cell line.

Authors:  K Totsuka; K Oshimi; H Mizoguchi
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

6.  DEP-Dots for 3D cell culture: low-cost, high-repeatability, effective 3D cell culture in multiple gel systems.

Authors:  Erin A Henslee; Carina M Dunlop; Christine M de Mel; Emily A Carter; Rula G Abdallat; Patrizia Camelliti; Fatima H Labeed
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.